JACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

Neurology-Clinical Practice, published by Lippincott Williams & Wilkins, is a prominent journal in the field of clinical neurology, catering to a diverse readership including researchers, healthcare professionals, and students. With an ISSN of 2163-0402 and an E-ISSN of 2163-0933, this journal has made significant contributions to the field since its inception in 2011, providing high-quality, peer-reviewed articles that address cutting-edge practices and research advancements in neurology. Currently positioned in the Q3 quartile for clinical neurology and ranking in the 51st percentile among the Scopus Medicine _ Neurology (clinical) category, the journal serves as a valuable resource for those looking to enhance their understanding and practice within this critical discipline. Authors and readers alike can expect a wealth of insightful content focused on the latest clinical techniques, patient care strategies, and innovative research findings, fostering a deeper comprehension of neurological disorders and their management. With a commitment to excellence, Neurology-Clinical Practice aims to bridge the gap between research and clinical application, thereby inspiring continued development in the dynamic field of neurology.

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.

Current Cardiology Reports, published by Springer, is a leading peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. With its ISSN 1523-3782 and E-ISSN 1534-3170, the journal offers a platform for researchers and practitioners to share innovative research findings, clinical insights, and comprehensive reviews, contributing to the ongoing dialogue in cardiovascular health. Recognized for its high impact, Current Cardiology Reports holds a prestigious Q1 ranking in the Cardiology category for 2023 and ranks #83 out of 387 in Scopus, placing it in the 78th percentile among journals in its field. The journal, converging its insights from 1999 to 2024, aims to disseminate valuable knowledge that can inform clinical practice and influence future research directions. Although not an Open Access journal, the rich content and timely articles published within its pages are invaluable to both seasoned professionals and emerging scholars in cardiology. Based in New York, United States, the journal continues to play a critical role in shaping cardiovascular medicine through rigorous scientific inquiry and education.

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.

Neonatal Network, published by Springer Publishing Co, is a respected journal in the field of Critical Care and Intensive Care Medicine, focusing on the complexities of neonatal health and development. With an ISSN of 0730-0832 and an E-ISSN of 1539-2880, this journal has been a vital resource for practitioners, researchers, and students since its inception in 1985. Covering a pivotal scope that encompasses Critical Care Nursing, Pediatrics, and Perinatology, it aims to enhance the understanding and treatment of newborns in critical conditions. Although categorized in the Q3 and Q4 quartiles by Scopus for 2023, its contributions remain significant, fostering a platform where innovative research and clinical wisdom converge for the benefit of neonatal care. As a non-open access journal, it provides insightful articles that are pivotal for enhancing neonatal practices and outcomes, ensuring its relevance as a distinguished academic outlet through 2024. The journal's rich history and focus on interdisciplinary collaboration make it an essential resource for those committed to advancing neonatal health.

Circulation-Cardiovascular Interventions, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal in the field of cardiology and cardiovascular medicine, recognized for its commitment to advancing the understanding and treatment of cardiovascular diseases. With a robust Impact Factor and ranking in the top 10% of its category, it serves as an essential resource for researchers, clinicians, and students seeking to stay at the forefront of cardiovascular intervention developments. This esteemed journal covers a range of topics, including innovative therapeutic strategies, cutting-edge clinical trials, and comprehensive reviews that inform clinical practice and influence guidelines. Since its inception in 2008, and extending through 2024, Circulation-Cardiovascular Interventions has published pivotal research that shapes the landscape of cardiovascular care in the United States and beyond. Its commitment to high-quality publications makes it an invaluable platform for sharing knowledge and fostering collaboration within the global medical community.

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.